Inventor
UNVERDORBEN FELIX
DE14 patents
⚠️ This page may combine multiple inventors who share the name “UNVERDORBEN FELIX”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMATICS BIOTECHNOLOGIES GMBH
13 patentsUS10618956B2Apr 14, 2020
Engineered T cell receptors and immune therapy using the same
IMMATICS BIOTECHNOLOGIES GMBH13 citations93
US11104894B2Aug 31, 2021
Method for preparing electrocompetent yeast cells, and method for using said cells
IMMATICS BIOTECHNOLOGIES GMBH3 citations72
US10889645B2Jan 12, 2021
Engineered T cell receptors and immune therapy using the same
IMMATICS BIOTECHNOLOGIES GMBH3 citations72
US10683495B2Jun 16, 2020
Method for preparing electrocompetent yeast cells, and method for using said cells
IMMATICS BIOTECHNOLOGIES GMBH3 citations72
US11840577B2Dec 12, 2023
Antigen binding proteins specifically binding MAGE-A
IMMATICS BIOTECHNOLOGIES GMBH2 citations70
US11932689B2Mar 19, 2024
Engineered T cell receptors and immune therapy using the same
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12269881B2Apr 8, 2025
Antigen binding proteins specifically binding MAGE-A
IMMATICS BIOTECHNOLOGIES GMBH0 citations60
US12570760B2Mar 10, 2026
Antigen binding proteins specifically binding PRAME
IMMATICS BIOTECHNOLOGIES GMBH0 citations58
US11859009B2Jan 2, 2024
Antigen binding proteins specifically binding PRAME
IMMATICS BIOTECHNOLOGIES GMBH0 citations58
US12209137B2Jan 28, 2025
Antigen binding proteins specifically binding CT45
IMMATICS BIOTECHNOLOGIES GMBH0 citations56
US11905328B2Feb 20, 2024
Dual specificity polypeptide molecule
IMMATICS BIOTECHNOLOGIES GMBH0 citations52
US12162940B2Dec 10, 2024
BMA031 antigen binding polypeptides
IMMATICS BIOTECHNOLOGIES GMBH0 citations51
US12480958B2Nov 25, 2025
Method for the characterization of peptide:MHC binding polypeptides
IMMATICS BIOTECHNOLOGIES GMBH0 citations49